>>9121814

>>9121489

gates' saving the world in 2017 with antiretroviral implant deal… kek, yeh right

https://www.queerty.com/bill-melinda-gates-invested-140-million-new-prep-pump-device-20170103

Massachusetts-based pharmaceutical company Intarcia Therapeutics is moving forward with plans to market a subcutaneous device that would deliver a daily dose of the anti-retroviral medicine.

Related: Bill Gates Continues Mission To Save World, You

They’ve just secured $206 million in funding to better research the mini-osmotic pump; a tiny implant that is inserted beneath the skin in order to treat chronic illnesses like HIV and Type II diabetes.

According to an announcement, $140 million of that money is being funded by the Bill & Melinda Gates Foundation, which was set up by the entrepreneur and his wife to help eliminate preventable diseases in some of the most impoverished parts of the world.

>>9122020

>cure for memes

kek, not habbening

>>9122047

>These guys (gates and associates) need to be FULLY exposed before they damange the world permanently

on that! digging, check out the below

>>9122049

>anybody suppose mel could be his handler

Of course I think that. Imagine how MK ultra works they are repeatedly sodomized and forced through satanic ritual abuse to produce fractured minds/ alters. The ones that successfully fracture are allowed to live and become the next gen of controlled communits leaders of Amerika. Of course they get set up with a big dick handler to conveniently apply sodomization as need for control of the asshat errrrr asset.

Intarcia DIG beginnings..

that name, got me thinking of antartica. haven't found that connection, yet.

But check out the CEO for starters. That's some handy awards and big numbers he's put together.

>>9122107

forgot the sauce and the info

must be excited

https://www.intarcia.com/about/leadership-team.html#

Kurt Graves has been Chairman, President and CEO of Intarcia since April 2012, having previously served solely as Executive Chairman of the company since August 2010, and as Acting CEO since October 2011. During his time at Intarcia, his influence on the Company’s vision, purpose and values has transformed not only its business goals, but also how it goes about its business. Since he joined, Intarcia successfully raised more than $1 billion in capital through very creative financings and strategic partnerships. Kurt was named the 2015 EY Entrepreneur of the Year in New England, and Intarcia was cited as a “Unicorn” company worth watching in a cover story of Fortune Magazine, and a 2015 “Disruptor 50” company by CNBC. Kurt is a global industry leader with more than twenty years of U.S. and global general management experience at top-tier U.S. and European based pharmaceutical and biotech companies. He has successfully built and managed several of the largest multi-billion dollar franchises in the industry and developed and launched more than 10 blockbuster brands in a broad range of general medicine, specialty and orphan disease areas. In addition to driving dynamic top and bottom-line growth in large global pharmaceutical companies, Kurt also played a key leadership role in building two highly successful early stage companies: Astra Merck Pharmaceuticals and Vertex Pharmaceuticals. Prior to joining Intarcia, Kurt was EVP, Chief Commercial Officer, and Head of Corporate and Strategic Development at Vertex Pharmaceuticals. Before his tenure at Vertex, he spent nearly ten years at Novartis Pharmaceuticals, most recently on the Executive Committee as Global Head of the General Medicines Business Unit & Chief Marketing Officer for the Pharmaceuticals division. Prior to Novartis, Kurt held several commercial and general management positions at Merck and Astra Merck/Astra Pharmaceuticals where he spent most of his time leading the GI Business Unit responsible for Prilosec® and Nexium®. In addition to his current responsibility at Intarcia, serves as Chairman of the Board of Radius® Health, Inc. (RDUS), and Seres Therapeutics (MCRB).

Kurt earned his B.S. in Biology from Hillsdale College and has attended numerous executive leadership programs at Harvard, Wharton School of Management and University of Michigan.

Learn more about Mr. Graves' background and approach in this article from "Life Science Leader."